Log in to save to my catalogue

Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap

Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10726830

Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap

About this item

Full title

Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap

Publisher

United States: Springer Nature B.V

Journal title

Cureus, 2023-11, Vol.15 (11), p.e49007-e49007

Language

English

Formats

Publication information

Publisher

United States: Springer Nature B.V

More information

Scope and Contents

Contents

Immune checkpoint inhibitors (ICIs) have considerably changed the management of several malignancies. Although these agents transformed the scope of management in oncology and proved long-term efficacy, they have been associated with numerous autoimmune-related adverse events. We presented a case of a 61-year-old male with a history of non-small ce...

Alternative Titles

Full title

Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10726830

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10726830

Other Identifiers

ISSN

2168-8184

E-ISSN

2168-8184

DOI

10.7759/cureus.49007

How to access this item